English
简体中文
Total: £ 56.28
Published Date: 2025-07-16 | Pages: 95 | Tables: 91 | Pharma & Healthcare
The global market for Steroid Induced Glaucoma was valued at US$ 1124 million in the year 2024 and is projected to reach a revised size of US$ 1722 million by 2031, growing at a CAGR of 6.1% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Steroid Induced Glaucoma competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Steroid-induced glaucoma is a form of secondary open-angle glaucoma that occurs due to prolonged or excessive use of corticosteroids—whether administered topically (eye drops), systemically (oral or injectable), inhaled, or periocularly. The corticosteroids cause increased resistance to aqueous humor outflow through the trabecular meshwork, leading to elevated intraocular pressure (IOP), which, if left untreated, can damage the optic nerve and lead to permanent vision loss. Individuals with a personal or family history of glaucoma, children, and patients on long-term steroid therapy are at higher risk.
North American market for Steroid Induced Glaucoma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Steroid Induced Glaucoma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Steroid Induced Glaucoma include Novartis, AbbVie, Bausch & Lomb, Pfizer, Thea Pharma, Sun Pharmaceutical, Ocular Therapeutix, Glaukos, Alcon, Santen Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Steroid Induced Glaucoma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Steroid Induced Glaucoma.
The Steroid Induced Glaucoma market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Steroid Induced Glaucoma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Steroid Induced Glaucoma manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novartis
AbbVie
Bausch & Lomb
Pfizer
Thea Pharma
Sun Pharmaceutical
Ocular Therapeutix
Glaukos
Alcon
Santen Pharmaceutical
SpyGlass Pharma
Segment by Type
Prednisolone
Dexamethasone
Other
Segment by Application
Hospital
Retail Pharmacy
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Steroid Induced Glaucoma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Steroid Induced Glaucoma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Steroid Induced Glaucoma Market Overview
1.1 Product Definition
1.2 Steroid Induced Glaucoma by Type
1.2.1 Global Steroid Induced Glaucoma Market Value Comparison by Type (2024 VS 2031)
1.2.2 Prednisolone
1.2.3 Dexamethasone
1.2.4 Other
1.3 Steroid Induced Glaucoma by Application
1.3.1 Global Steroid Induced Glaucoma Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Steroid Induced Glaucoma Market Size Estimates and Forecasts
1.4.1 Global Steroid Induced Glaucoma Revenue 2020-2031
1.4.2 Global Steroid Induced Glaucoma Sales 2020-2031
1.4.3 Global Steroid Induced Glaucoma Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Steroid Induced Glaucoma Market Competition by Manufacturers
2.1 Global Steroid Induced Glaucoma Sales Market Share by Manufacturers (2020-2025)
2.2 Global Steroid Induced Glaucoma Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Steroid Induced Glaucoma Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Steroid Induced Glaucoma, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Steroid Induced Glaucoma, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Steroid Induced Glaucoma, Product Type & Application
2.7 Global Key Manufacturers of Steroid Induced Glaucoma, Date of Enter into This Industry
2.8 Global Steroid Induced Glaucoma Market Competitive Situation and Trends
2.8.1 Global Steroid Induced Glaucoma Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Steroid Induced Glaucoma Players Market Share by Revenue
2.8.3 Global Steroid Induced Glaucoma Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Steroid Induced Glaucoma Market Scenario by Region
3.1 Global Steroid Induced Glaucoma Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Steroid Induced Glaucoma Sales by Region: 2020-2031
3.2.1 Global Steroid Induced Glaucoma Sales by Region: 2020-2025
3.2.2 Global Steroid Induced Glaucoma Sales by Region: 2026-2031
3.3 Global Steroid Induced Glaucoma Revenue by Region: 2020-2031
3.3.1 Global Steroid Induced Glaucoma Revenue by Region: 2020-2025
3.3.2 Global Steroid Induced Glaucoma Revenue by Region: 2026-2031
3.4 North America Steroid Induced Glaucoma Market Facts & Figures by Country
3.4.1 North America Steroid Induced Glaucoma Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Steroid Induced Glaucoma Sales by Country (2020-2031)
3.4.3 North America Steroid Induced Glaucoma Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Steroid Induced Glaucoma Market Facts & Figures by Country
3.5.1 Europe Steroid Induced Glaucoma Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Steroid Induced Glaucoma Sales by Country (2020-2031)
3.5.3 Europe Steroid Induced Glaucoma Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Steroid Induced Glaucoma Market Facts & Figures by Region
3.6.1 Asia Pacific Steroid Induced Glaucoma Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Steroid Induced Glaucoma Sales by Region (2020-2031)
3.6.3 Asia Pacific Steroid Induced Glaucoma Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Steroid Induced Glaucoma Market Facts & Figures by Country
3.7.1 Latin America Steroid Induced Glaucoma Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Steroid Induced Glaucoma Sales by Country (2020-2031)
3.7.3 Latin America Steroid Induced Glaucoma Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Steroid Induced Glaucoma Market Facts & Figures by Country
3.8.1 Middle East and Africa Steroid Induced Glaucoma Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Steroid Induced Glaucoma Sales by Country (2020-2031)
3.8.3 Middle East and Africa Steroid Induced Glaucoma Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Steroid Induced Glaucoma Sales by Type (2020-2031)
4.1.1 Global Steroid Induced Glaucoma Sales by Type (2020-2025)
4.1.2 Global Steroid Induced Glaucoma Sales by Type (2026-2031)
4.1.3 Global Steroid Induced Glaucoma Sales Market Share by Type (2020-2031)
4.2 Global Steroid Induced Glaucoma Revenue by Type (2020-2031)
4.2.1 Global Steroid Induced Glaucoma Revenue by Type (2020-2025)
4.2.2 Global Steroid Induced Glaucoma Revenue by Type (2026-2031)
4.2.3 Global Steroid Induced Glaucoma Revenue Market Share by Type (2020-2031)
4.3 Global Steroid Induced Glaucoma Price by Type (2020-2031)
5 Segment by Application
5.1 Global Steroid Induced Glaucoma Sales by Application (2020-2031)
5.1.1 Global Steroid Induced Glaucoma Sales by Application (2020-2025)
5.1.2 Global Steroid Induced Glaucoma Sales by Application (2026-2031)
5.1.3 Global Steroid Induced Glaucoma Sales Market Share by Application (2020-2031)
5.2 Global Steroid Induced Glaucoma Revenue by Application (2020-2031)
5.2.1 Global Steroid Induced Glaucoma Revenue by Application (2020-2025)
5.2.2 Global Steroid Induced Glaucoma Revenue by Application (2026-2031)
5.2.3 Global Steroid Induced Glaucoma Revenue Market Share by Application (2020-2031)
5.3 Global Steroid Induced Glaucoma Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Steroid Induced Glaucoma Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Steroid Induced Glaucoma Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Steroid Induced Glaucoma Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AbbVie Steroid Induced Glaucoma Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Bausch & Lomb
6.3.1 Bausch & Lomb Company Information
6.3.2 Bausch & Lomb Description and Business Overview
6.3.3 Bausch & Lomb Steroid Induced Glaucoma Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bausch & Lomb Steroid Induced Glaucoma Product Portfolio
6.3.5 Bausch & Lomb Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Steroid Induced Glaucoma Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Steroid Induced Glaucoma Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Thea Pharma
6.5.1 Thea Pharma Company Information
6.5.2 Thea Pharma Description and Business Overview
6.5.3 Thea Pharma Steroid Induced Glaucoma Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Thea Pharma Steroid Induced Glaucoma Product Portfolio
6.5.5 Thea Pharma Recent Developments/Updates
6.6 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Company Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Steroid Induced Glaucoma Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sun Pharmaceutical Steroid Induced Glaucoma Product Portfolio
6.6.5 Sun Pharmaceutical Recent Developments/Updates
6.7 Ocular Therapeutix
6.7.1 Ocular Therapeutix Company Information
6.7.2 Ocular Therapeutix Description and Business Overview
6.7.3 Ocular Therapeutix Steroid Induced Glaucoma Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ocular Therapeutix Steroid Induced Glaucoma Product Portfolio
6.7.5 Ocular Therapeutix Recent Developments/Updates
6.8 Glaukos
6.8.1 Glaukos Company Information
6.8.2 Glaukos Description and Business Overview
6.8.3 Glaukos Steroid Induced Glaucoma Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Glaukos Steroid Induced Glaucoma Product Portfolio
6.8.5 Glaukos Recent Developments/Updates
6.9 Alcon
6.9.1 Alcon Company Information
6.9.2 Alcon Description and Business Overview
6.9.3 Alcon Steroid Induced Glaucoma Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Alcon Steroid Induced Glaucoma Product Portfolio
6.9.5 Alcon Recent Developments/Updates
6.10 Santen Pharmaceutical
6.10.1 Santen Pharmaceutical Company Information
6.10.2 Santen Pharmaceutical Description and Business Overview
6.10.3 Santen Pharmaceutical Steroid Induced Glaucoma Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Santen Pharmaceutical Steroid Induced Glaucoma Product Portfolio
6.10.5 Santen Pharmaceutical Recent Developments/Updates
6.11 SpyGlass Pharma
6.11.1 SpyGlass Pharma Company Information
6.11.2 SpyGlass Pharma Description and Business Overview
6.11.3 SpyGlass Pharma Steroid Induced Glaucoma Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SpyGlass Pharma Steroid Induced Glaucoma Product Portfolio
6.11.5 SpyGlass Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Steroid Induced Glaucoma Industry Chain Analysis
7.2 Steroid Induced Glaucoma Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Steroid Induced Glaucoma Production Mode & Process Analysis
7.4 Steroid Induced Glaucoma Sales and Marketing
7.4.1 Steroid Induced Glaucoma Sales Channels
7.4.2 Steroid Induced Glaucoma Distributors
7.5 Steroid Induced Glaucoma Customer Analysis
8 Steroid Induced Glaucoma Market Dynamics
8.1 Steroid Induced Glaucoma Industry Trends
8.2 Steroid Induced Glaucoma Market Drivers
8.3 Steroid Induced Glaucoma Market Challenges
8.4 Steroid Induced Glaucoma Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Steroid Induced Glaucoma Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Steroid Induced Glaucoma Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Steroid Induced Glaucoma Market Competitive Situation by Manufacturers in 2024
Table 4. Global Steroid Induced Glaucoma Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Steroid Induced Glaucoma Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Steroid Induced Glaucoma Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Steroid Induced Glaucoma Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Steroid Induced Glaucoma Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Steroid Induced Glaucoma, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Steroid Induced Glaucoma, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Steroid Induced Glaucoma, Product Type & Application
Table 12. Global Key Manufacturers of Steroid Induced Glaucoma, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Steroid Induced Glaucoma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Steroid Induced Glaucoma as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Steroid Induced Glaucoma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Steroid Induced Glaucoma Sales by Region (2020-2025) & (K Units)
Table 18. Global Steroid Induced Glaucoma Sales Market Share by Region (2020-2025)
Table 19. Global Steroid Induced Glaucoma Sales by Region (2026-2031) & (K Units)
Table 20. Global Steroid Induced Glaucoma Sales Market Share by Region (2026-2031)
Table 21. Global Steroid Induced Glaucoma Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Steroid Induced Glaucoma Revenue Market Share by Region (2020-2025)
Table 23. Global Steroid Induced Glaucoma Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Steroid Induced Glaucoma Revenue Market Share by Region (2026-2031)
Table 25. North America Steroid Induced Glaucoma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Steroid Induced Glaucoma Sales by Country (2020-2025) & (K Units)
Table 27. North America Steroid Induced Glaucoma Sales by Country (2026-2031) & (K Units)
Table 28. North America Steroid Induced Glaucoma Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Steroid Induced Glaucoma Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Steroid Induced Glaucoma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Steroid Induced Glaucoma Sales by Country (2020-2025) & (K Units)
Table 32. Europe Steroid Induced Glaucoma Sales by Country (2026-2031) & (K Units)
Table 33. Europe Steroid Induced Glaucoma Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Steroid Induced Glaucoma Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Steroid Induced Glaucoma Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Steroid Induced Glaucoma Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Steroid Induced Glaucoma Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Steroid Induced Glaucoma Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Steroid Induced Glaucoma Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Steroid Induced Glaucoma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Steroid Induced Glaucoma Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Steroid Induced Glaucoma Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Steroid Induced Glaucoma Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Steroid Induced Glaucoma Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Steroid Induced Glaucoma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Steroid Induced Glaucoma Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Steroid Induced Glaucoma Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Steroid Induced Glaucoma Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Steroid Induced Glaucoma Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Steroid Induced Glaucoma Sales (K Units) by Type (2020-2025)
Table 51. Global Steroid Induced Glaucoma Sales (K Units) by Type (2026-2031)
Table 52. Global Steroid Induced Glaucoma Sales Market Share by Type (2020-2025)
Table 53. Global Steroid Induced Glaucoma Sales Market Share by Type (2026-2031)
Table 54. Global Steroid Induced Glaucoma Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Steroid Induced Glaucoma Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Steroid Induced Glaucoma Revenue Market Share by Type (2020-2025)
Table 57. Global Steroid Induced Glaucoma Revenue Market Share by Type (2026-2031)
Table 58. Global Steroid Induced Glaucoma Price (US$/Unit) by Type (2020-2025)
Table 59. Global Steroid Induced Glaucoma Price (US$/Unit) by Type (2026-2031)
Table 60. Global Steroid Induced Glaucoma Sales (K Units) by Application (2020-2025)
Table 61. Global Steroid Induced Glaucoma Sales (K Units) by Application (2026-2031)
Table 62. Global Steroid Induced Glaucoma Sales Market Share by Application (2020-2025)
Table 63. Global Steroid Induced Glaucoma Sales Market Share by Application (2026-2031)
Table 64. Global Steroid Induced Glaucoma Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Steroid Induced Glaucoma Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Steroid Induced Glaucoma Revenue Market Share by Application (2020-2025)
Table 67. Global Steroid Induced Glaucoma Revenue Market Share by Application (2026-2031)
Table 68. Global Steroid Induced Glaucoma Price (US$/Unit) by Application (2020-2025)
Table 69. Global Steroid Induced Glaucoma Price (US$/Unit) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Steroid Induced Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novartis Steroid Induced Glaucoma Product
Table 74. Novartis Recent Developments/Updates
Table 75. AbbVie Company Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Steroid Induced Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. AbbVie Steroid Induced Glaucoma Product
Table 79. AbbVie Recent Developments/Updates
Table 80. Bausch & Lomb Company Information
Table 81. Bausch & Lomb Description and Business Overview
Table 82. Bausch & Lomb Steroid Induced Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Bausch & Lomb Steroid Induced Glaucoma Product
Table 84. Bausch & Lomb Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Steroid Induced Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Steroid Induced Glaucoma Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Thea Pharma Company Information
Table 91. Thea Pharma Description and Business Overview
Table 92. Thea Pharma Steroid Induced Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Thea Pharma Steroid Induced Glaucoma Product
Table 94. Thea Pharma Recent Developments/Updates
Table 95. Sun Pharmaceutical Company Information
Table 96. Sun Pharmaceutical Description and Business Overview
Table 97. Sun Pharmaceutical Steroid Induced Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Sun Pharmaceutical Steroid Induced Glaucoma Product
Table 99. Sun Pharmaceutical Recent Developments/Updates
Table 100. Ocular Therapeutix Company Information
Table 101. Ocular Therapeutix Description and Business Overview
Table 102. Ocular Therapeutix Steroid Induced Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Ocular Therapeutix Steroid Induced Glaucoma Product
Table 104. Ocular Therapeutix Recent Developments/Updates
Table 105. Glaukos Company Information
Table 106. Glaukos Description and Business Overview
Table 107. Glaukos Steroid Induced Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Glaukos Steroid Induced Glaucoma Product
Table 109. Glaukos Recent Developments/Updates
Table 110. Alcon Company Information
Table 111. Alcon Description and Business Overview
Table 112. Alcon Steroid Induced Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Alcon Steroid Induced Glaucoma Product
Table 114. Alcon Recent Developments/Updates
Table 115. Santen Pharmaceutical Company Information
Table 116. Santen Pharmaceutical Description and Business Overview
Table 117. Santen Pharmaceutical Steroid Induced Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Santen Pharmaceutical Steroid Induced Glaucoma Product
Table 119. Santen Pharmaceutical Recent Developments/Updates
Table 120. SpyGlass Pharma Company Information
Table 121. SpyGlass Pharma Description and Business Overview
Table 122. SpyGlass Pharma Steroid Induced Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. SpyGlass Pharma Steroid Induced Glaucoma Product
Table 124. SpyGlass Pharma Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Steroid Induced Glaucoma Distributors List
Table 128. Steroid Induced Glaucoma Customers List
Table 129. Steroid Induced Glaucoma Market Trends
Table 130. Steroid Induced Glaucoma Market Drivers
Table 131. Steroid Induced Glaucoma Market Challenges
Table 132. Steroid Induced Glaucoma Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Steroid Induced Glaucoma
Figure 2. Global Steroid Induced Glaucoma Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Steroid Induced Glaucoma Market Share by Type: 2024 & 2031
Figure 4. Prednisolone Product Picture
Figure 5. Dexamethasone Product Picture
Figure 6. Other Product Picture
Figure 7. Global Steroid Induced Glaucoma Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Steroid Induced Glaucoma Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Others
Figure 12. Global Steroid Induced Glaucoma Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Steroid Induced Glaucoma Market Size (2020-2031) & (US$ Million)
Figure 14. Global Steroid Induced Glaucoma Sales (2020-2031) & (K Units)
Figure 15. Global Steroid Induced Glaucoma Average Price (US$/Unit) & (2020-2031)
Figure 16. Steroid Induced Glaucoma Report Years Considered
Figure 17. Steroid Induced Glaucoma Sales Share by Manufacturers in 2024
Figure 18. Global Steroid Induced Glaucoma Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Steroid Induced Glaucoma Players: Market Share by Revenue in Steroid Induced Glaucoma in 2024
Figure 20. Steroid Induced Glaucoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Steroid Induced Glaucoma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Steroid Induced Glaucoma Sales Market Share by Country (2020-2031)
Figure 23. North America Steroid Induced Glaucoma Revenue Market Share by Country (2020-2031)
Figure 24. United States Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Steroid Induced Glaucoma Sales Market Share by Country (2020-2031)
Figure 27. Europe Steroid Induced Glaucoma Revenue Market Share by Country (2020-2031)
Figure 28. Germany Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Steroid Induced Glaucoma Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Steroid Induced Glaucoma Revenue Market Share by Region (2020-2031)
Figure 35. China Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Steroid Induced Glaucoma Sales Market Share by Country (2020-2031)
Figure 43. Latin America Steroid Induced Glaucoma Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Steroid Induced Glaucoma Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Steroid Induced Glaucoma Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Steroid Induced Glaucoma Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Steroid Induced Glaucoma by Type (2020-2031)
Figure 54. Global Revenue Market Share of Steroid Induced Glaucoma by Type (2020-2031)
Figure 55. Global Steroid Induced Glaucoma Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Steroid Induced Glaucoma by Application (2020-2031)
Figure 57. Global Revenue Market Share of Steroid Induced Glaucoma by Application (2020-2031)
Figure 58. Global Steroid Induced Glaucoma Price (US$/Unit) by Application (2020-2031)
Figure 59. Steroid Induced Glaucoma Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
